# MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer

> **NCT04082182** · PHASE1 · UNKNOWN · sponsor: **University Hospital, Ghent** · enrollment: 7 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic

## Interventions

- **BIOLOGICAL:** Dendritic cell immunotherapy
- **BIOLOGICAL:** Antigen-specific DTH
- **BIOLOGICAL:** Control DTH

## Key facts

- **NCT ID:** NCT04082182
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-26
- **Primary completion:** 2021-06-07
- **Final completion:** 2021-12-31
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082182, "MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04082182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*